Derma Brilliance Sunscreen SPF 30 (Allure Labs, Inc)
Welcome to the PulseAid listing for the Derma Brilliance Sunscreen SPF 30 drug offered from Allure Labs, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Allure Labs, Inc |
NON-PROPRIETARY NAME: | Octinoxate, Oxybenzone, Octisalate, Avobenzone and Octocrylene |
SUBSTANCE NAME: | OCTINOXATE; OXYBENZONE; OCTISALATE; AVOBENZONE; OCTOCRYLENE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2015-03-17 |
END MARKETING DATE: | 0000-00-00 |
Derma Brilliance Sunscreen SPF 30 HUMAN OTC DRUG Details:
Item Description | Derma Brilliance Sunscreen SPF 30 from Allure Labs, Inc |
LABELER NAME: | Allure Labs, Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 7.5; 6; 5; 2; 1.5(mg/g; mg/g; mg/g; mg/g; mg/g) |
START MARKETING DATE: | 2015-03-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62742-4073_2cf57334-fa04-41f3-964d-edbe1dc8f31e |
PRODUCT NDC: | 62742-4073 |
APPLICATION NUMBER: | part352 |
Other OCTINOXATE; OXYBENZONE; OCTISALATE; AVOBENZONE; OCTOCRYLENE Pharmaceutical Manufacturers / Labelers: